[Differences in the antigenic structure of chromatin from the liver and hepatoma cells in the rat]
- PMID: 6209092
[Differences in the antigenic structure of chromatin from the liver and hepatoma cells in the rat]
Abstract
Differences in antigenic structure of chromatin from normal and tumour cells were studied using rabbit antibodies against chromatin of the rat liver, Zaidela ascite hepatoma and solid hepatoma 27 cells. It is shown that carcinogenesis is accompanied by loss of a part of normal liver antigens. All the antigens which are not indicated in solid hepatoma were not detected in ascite tumour too. The latter is deficient in some antigens common for the normal liver and solid hepatoma cells. Chromatin of both hepatomas contains antigens which are not detected in liver chromatin. Hepatoma 27 contains also antigens detected in this tumour only. At least some antigens of tumour cells are not found in regenerating liver and in liver cells of newborn rats. Antigenic properties of liver cells chromatin in old (30 months) rats approach to those of hepatoma cells chromatin.
Similar articles
-
[Localization of antigens in the chromatin of normal rat liver cells, not detectable in hepatoma chromatin].Biokhimiia. 1984 Jun;49(6):938-42. Biokhimiia. 1984. PMID: 6331856 Russian.
-
[Intranuclear localization of hepatoma chromatin antigens not detected in liver chromatin].Eksp Onkol. 1984;6(5):39-42. Eksp Onkol. 1984. PMID: 6510342 Russian.
-
Some antigenic similarity between nonhistone protein-DNA complexes from chromatin of the cells of Zajdela hepatoma and liver of rats subjected to a single 4-dimethylaminoazobenzene injection.Neoplasma. 1981;28(1):27-34. Neoplasma. 1981. PMID: 6792549
-
Antigenic changes associated with liver carcinogenesis.J Toxicol Environ Health. 1979 Mar-May;5(2-3):453-68. doi: 10.1080/15287397909529759. J Toxicol Environ Health. 1979. PMID: 89200 Review.
-
[Association of embryonic antigens with hepatoma and other liver diseases in rats. Current state of the question].Laval Med. 1969 Oct;40(8):772-98 concl. Laval Med. 1969. PMID: 5400996 Review. French. No abstract available.
Cited by
-
Optimizing symptom control in children and adolescents with cancer.Pediatr Res. 2019 Nov;86(5):573-578. doi: 10.1038/s41390-019-0516-3. Epub 2019 Jul 29. Pediatr Res. 2019. PMID: 31357207 Review.